Auxilium

News

This section provides essential news and information about Auxilium.

  • Press Releases - get the latest corporate information about Auxilium
  • Archive - see a complete listing of past press releases about Auxilium
  • Investor Kit - contact us to receive the latest investor relations information

For Investors - additional information and resources designed with investors in mind.

Recent News
DateTitle 
Jun 26, 2014Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT
Accelerates Auxilium's Ongoing Transformation Into Leading North American Specialty Biopharmaceutical Company Canadian-Domiciled Structure Creates Stronger Financial Position, Competitive Partnering and M&A Platform Platform Enables Continued Product and Therapeutic Diversification; Expands Geographic Footprint CHESTERBROOK, Pa. and VANCOUVER, Canada, June 26, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company... 
Printer Friendly Version
Jun 25, 2014Sobi files for EU approval of Xiapex for Peyronies disease
STOCKHOLM and CHESTERBROOK, Pa., June 25, 2014 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) and Auxilium Pharmaceuticals, Inc. today announced that Sobi has filed for an extension of the label for Xiapex® (collagenase clostridium histolyticum) with the European Medicines Agency (EMA) to include the indication of Peyronie's disease. The filing is based on positive safety and efficacy outcome data from two double-blind placebo-controlled studies, IMPRESS I and II (The Investigation... 
Printer Friendly Version
Jun 11, 2014Auxilium Pharmaceuticals, Inc. Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel)
CHESTERBROOK, Pa., June 11, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that it has partnered with Prasco, LLC ("Prasco") to introduce an Authorized Generic version of Testim® (testosterone gel). Prasco has product inventory available and has commenced shipping product. Testim and its Authorized Generic version are testosterone gels approved by the U.S. Food and Drug Administration to treat adult male... 
Printer Friendly Version
Jun 2, 2014Auxilium Pharmaceuticals, Inc. Announces Departure of Chief Financial Officer
CHESTERBROOK, Pa., June 2, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that James E. Fickenscher, Chief Financial Officer, is leaving the Company to pursue other interests. Mr. Fickenscher will continue in his current role through August 15, 2014. "The Board and I want to thank Jim for his nine years of service and important contributions to the evolution of Auxilium," said Adrian Adams, Chief Exe... 
Printer Friendly Version